A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
Recruiting · NCT06883539 · Registry updated 2025-03-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, endocrine system disorder, epithelial neoplasm, hepatocellular carcinoma, kidney cancer, kidney disorder, liver disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, renal cell carcinoma, urinary system disorder | Recruiting | Phase 1 | 2025-03-19 | NCT06883539 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Efficient Pharma Management Corp. | 2 |
| LaunXP Biomedical Co., Ltd. | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| China Medical University Hospital | Taichung | Taiwan | 36 |
| National Cheng Kung University Hospital | Tainan | Taiwan | 135 |